Myfembree is a medicine for heavy periods caused by fibroids and for pain from endometriosis. It is one pill taken by mouth every day. One part lowers the hormones that drive bleeding and pain, and small doses of two other hormones help protect your bones.
Every report comes from a Lived member, sent anonymously.
Have you tried Myfembree (Relugolix / Estradiol / Norethindrone) for Fibroids?
Myfembree is a once-daily prescription tablet for premenopausal women with one of two conditions. It treats heavy menstrual bleeding caused by uterine fibroids, the noncancerous growths in the muscle wall of the uterus, and it treats moderate to severe pain from endometriosis, a condition in which tissue similar to the uterine lining grows outside the uterus. The tablet combines three medicines. Relugolix lowers the body's own production of estrogen and progesterone, and small doses of estradiol (an estrogen) and norethindrone acetate (a progestin) are added back to limit the effects of very low estrogen, especially bone loss. Myfembree eases symptoms while it is taken rather than removing fibroids or endometriosis, and total treatment is limited to 24 months.
The menstrual cycle is run by a chain of hormone signals that starts in the brain. GnRH (gonadotropin-releasing hormone) prompts the pituitary gland to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone), and these tell the ovaries to make estrogen and progesterone. Fibroid bleeding and endometriosis pain both depend heavily on those ovarian hormones. Relugolix blocks the GnRH receptors on the pituitary, so less LH and FSH are released and the ovaries make far less estrogen and progesterone. Bleeding and pain fall as a result. On its own, that drop would act like an early menopause and thin the bones. The small dose of estradiol in the tablet partly replaces estrogen to reduce that bone loss, and norethindrone acetate protects the lining of the uterus, which can thicken abnormally when estrogen is given without a progestin.
Myfembree comes in a single strength and is taken as one tablet by mouth once a day, at about the same time, with or without food. Before the first dose, the prescriber makes sure you are not pregnant, and any hormonal birth control is stopped. The first tablet is taken as soon as possible after a period starts and no later than 7 days into it. Starting later in the cycle can bring irregular or heavier bleeding at first. If you miss a dose, take it as soon as you remember that same day, then return to the usual time the next day. Do not take two tablets to make up for a missed day.
Hot flashes, sweating and night sweats, irregular or unexpected vaginal bleeding, and lower interest in sex are among the most common side effects. People treated for endometriosis also commonly report headache, nausea, back or joint pain, tiredness, dizziness and mood changes. In the fibroid trials, some women had hair loss or thinning with no particular pattern, and it is not known whether it fully reverses after stopping. Blood pressure can rise, so it is checked during treatment. Depression, anxiety and other mood changes can begin or worsen, sometimes soon after starting, and are worth reporting to the prescriber promptly. Get medical help right away for any thoughts of suicide. Call the care team right away for yellowing of the skin or eyes, dark urine or pain in the upper right abdomen, which can signal a liver problem, and for sudden heavier bleeding or strong cramping, which in someone with fibroids can mean a fibroid is being pushed out of the uterus. Stop the medicine and get emergency care for signs of a blood clot, stroke or heart attack: leg pain or swelling that does not go away, sudden shortness of breath, pain or pressure in the chest, arm or jaw, a sudden severe headache unlike your usual ones, weakness or numbness in an arm or leg, trouble speaking, or sudden loss of vision or double vision.
Myfembree carries a boxed warning, the FDA's most prominent kind, because its estrogen and progestin raise the risk of blood clots in the legs or lungs, stroke and heart attack. It is not used by women who have had a blood clot, stroke or heart attack, who have blood vessel disease such as narrowed heart, brain or leg arteries, a clotting disorder or certain heart rhythm or valve problems, who are over 35 and smoke, who have uncontrolled high blood pressure, or who are over 35 and have migraine with aura. It is usually stopped 4 to 6 weeks before surgery that raises clot risk, and during long periods of bed rest. It is also not used by people with osteoporosis, breast cancer or another hormone-sensitive cancer, liver disease, or vaginal bleeding whose cause has not been found. Bone loss on Myfembree may not fully recover after stopping, which is why total use, across all periods of treatment, is capped at 24 months. Myfembree is not birth control, and it can cause early pregnancy loss. Use a non-hormonal method such as condoms during treatment and for one week after the last dose. Hormonal birth control is avoided because the extra estrogen raises side effect risks and can make Myfembree less effective. Because periods often become light or stop, a pregnancy can go unnoticed: take a test if pregnancy is possible, and stop the tablet and call the prescriber if you think you are pregnant. Estrogen and progestin can reduce breast milk supply, and relugolix passes into breast milk. Some medicines change relugolix levels, so ask a pharmacist or the prescriber to check every new medicine, including a short course of antibiotics. One group raises relugolix levels and side effect risk. It includes the antibiotics erythromycin (which raised levels about fourfold in testing) and clarithromycin, and some heart rhythm medicines such as amiodarone. These are best avoided; if one is needed, take Myfembree first and wait at least 6 hours before taking the other medicine. Another group lowers the levels of Myfembree's ingredients and can weaken its effect, so these combinations are generally avoided. It includes rifampin, an antibiotic used for tuberculosis, the seizure medicine carbamazepine, and the herbal supplement St. John's wort. If you take thyroid hormone or cortisol replacement, the estrogen in Myfembree raises the proteins that carry these hormones in the blood, leaving less of them free to act, so your replacement dose may need to go up. People with diabetes or high triglycerides may need closer checks of blood sugar or blood fats.
For fibroid bleeding, improvement can begin within the first month. In the main trials, about 7 in 10 women reached the study goal (blood loss cut by at least half and below 80 mL per cycle, the level used to define heavy bleeding) compared with fewer than 2 in 10 on placebo, and about half stopped having periods. For endometriosis, about 3 in 4 women had meaningful relief of period pain versus about 3 in 10 on placebo. Relief of pelvic pain between periods was smaller but still clear, about 6 in 10 versus 4 in 10. Treatment includes a bone density scan, called a DXA scan, at the start and again during treatment (yearly for endometriosis), along with blood pressure checks. Calcium and vitamin D may be advised if your diet is short on them. Myfembree controls symptoms only while it is taken. In a study of women who stopped after a year of treatment, heavy bleeding typically returned within about six weeks. Because of the 24-month limit, it helps to plan early with the prescriber what comes next, such as another medicine or a procedure.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Myfembree (Relugolix / Estradiol / Norethindrone), what you've noticed, or ask the community a question.